BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lai RM, Chen TB, Hu YH, Wu G, Zheng Q. Effect of type 2 diabetic mellitus in the prognosis of acute-on-chronic liver failure patients in China. World J Gastroenterol 2021; 27(23): 3372-3385 [PMID: 34163118 DOI: 10.3748/wjg.v27.i23.3372]
URL: https://www.wjgnet.com/1007-9327/full/v27/i23/3372.htm
Number Citing Articles
1
Nayyar Ashfaq, Akash John, Abid Ali, Amina Sharif Bhatti, Hateem Qaiser. Evaluation of Liver Changes in Type-2 Diabetes Mellitus Patients using Computed TomographyDIET FACTOR (Journal of Nutritional & Food Sciences) 2022; : 14 doi: 10.54393/df.v3i1.45
2
Han Hu, Xinxin Hu, Caiyun Tian, Yanping Zhu, Yujuan Liu, Qijiao Cheng, Fangwan Yang, Jun Liu, Ying Li, Shide Lin. Diabetes is associated with poor short-term prognosis in patients with hepatitis B virus-related acute-on-chronic liver failureHepatology International 2021; 15(5): 1093 doi: 10.1007/s12072-021-10243-1
3
Zeliha Coşgun, Melike Elif Kalfaoğlu. Comparative evaluation of hepatosteatosis in patients with type 2 diabetes mellitus using non-contrast abdominal CT and laboratory findingsNorthwestern Medical Journal 2024; 4(4): 188 doi: 10.54307/2024.NWMJ.95
4
Luyao Ma, Siqi Liu, Hao Xing, Zhenjing Jin. Research progress on short-term prognosis of acute-on-chronic liver failureExpert Review of Gastroenterology & Hepatology 2023; 17(1): 45 doi: 10.1080/17474124.2023.2165063
5
Wei Wang, Chen-Chen Pan, Wen-Ying Zhao, Jin-Yu Sheng, Qi-Qi Wu, Si-Si Chen. Comments on “Effect of type 2 diabetes mellitus in the prognosis of acute-on-chronic liver failure patients in China”World Journal of Gastroenterology 2022; 28(14): 1499-1502 doi: 10.3748/wjg.v28.i14.1499
6
Joseph J. Alukal, Feng Li, Paul J. Thuluvath. Liver Transplantation Within 7-Days of Listing Improves Survival in ACLF-3Digestive Diseases and Sciences 2023; 68(8): 3268 doi: 10.1007/s10620-023-08011-2
7
Ashok Choudhury, Ruveena Rajaram, Shiv Kumar Sarin. Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplierHepatology International 2024; 18(S2): 941 doi: 10.1007/s12072-024-10711-4